RAPT Ebitda from 2010 to 2024
| RAPT Stock | USD 4.01 0.04 0.99% |
EBITDA | First Reported 2018-03-31 | Previous Quarter -32.9 M | Current Value -32.2 M | Quarterly Volatility 8.4 M |
Check RAPT Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RAPT main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 1.3 M or Selling General Administrative of 14.6 M, as well as many exotic indicators such as Price To Sales Ratio of 208, Dividend Yield of 0.0 or PTB Ratio of 6.8. RAPT financial statements analysis is a perfect complement when working with RAPT Therapeutics Valuation or Volatility modules.
RAPT | Ebitda |
Latest RAPT Therapeutics' Ebitda Growth Pattern
Below is the plot of the Ebitda of RAPT Therapeutics over the last few years. It is RAPT Therapeutics' EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in RAPT Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Ebitda | 10 Years Trend |
|
Ebitda |
| Timeline |
RAPT Ebitda Regression Statistics
| Arithmetic Mean | (49,832,230) | |
| Coefficient Of Variation | (67.06) | |
| Mean Deviation | 26,231,640 | |
| Median | (27,947,000) | |
| Standard Deviation | 33,418,563 | |
| Sample Variance | 1116.8T | |
| Range | 95.6M | |
| R-Value | (0.84) | |
| Mean Square Error | 358.4T | |
| R-Squared | 0.70 | |
| Significance | 0.000096 | |
| Slope | (6,260,968) | |
| Total Sum of Squares | 15635.2T |
RAPT Ebitda History
About RAPT Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include RAPT Therapeutics income statement, its balance sheet, and the statement of cash flows. RAPT Therapeutics investors use historical funamental indicators, such as RAPT Therapeutics's Ebitda, to determine how well the company is positioned to perform in the future. Although RAPT Therapeutics investors may use each financial statement separately, they are all related. The changes in RAPT Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on RAPT Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on RAPT Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in RAPT Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| EBITDA | -123.5 M | -117.3 M |
Pair Trading with RAPT Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RAPT Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with RAPT Stock
| 0.65 | EQ | Equillium | PairCorr |
Moving against RAPT Stock
| 0.56 | VALN | Valneva SE ADR | PairCorr |
| 0.5 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to RAPT Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RAPT Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RAPT Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RAPT Therapeutics to buy it.
The correlation of RAPT Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RAPT Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RAPT Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RAPT Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of RAPT Therapeutics Correlation against competitors. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for RAPT Stock analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is RAPT Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.08) | Quarterly Revenue Growth (1.00) | Return On Assets (0.40) | Return On Equity (0.67) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.